블루제이 다이어그노스틱스(BJDX)는 NASDAQ에 상장된 Healthcare · Medical Devices 기업입니다. 현재가 $1.05 (-0.94%), 시가총액 $0.00B, 52주 범위 $0.65 ~ $3.62.
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed to provide measurements of key diagnostic biomarkers found in blood; and Symphony analyzer used to orchestrate sample processing of whole blood, plasma, serum, etc., biomarker isolation, and immunoassay preparation using non-contact centrifugal force. The company also develops Symphony IL-6 tests for the monitoring of disease progression in critical care settings. In addition, it develops additional tests for Symphony, such as tests for myocardial infraction and congestive heart failure, as well
블루제이 다이어그노스틱스의 재무제표, 목표주가, 기관투자자(13F) 보유 현황, 관련 뉴스는 BlackQuant에서 실시간으로 확인할 수 있습니다.
블루제이 다이어그노스틱스의 현재 주가는 $1.05 (-0.94%)입니다. BlackQuant에서 실시간 시세와 차트를 확인할 수 있습니다.
블루제이 다이어그노스틱스의 시가총액은 약 $0.00B입니다.
Bluejay Diagnostics, Inc. operates as a medical diagnostics company. It offers Symphony technology platform which consists of an analyzer and single-use protein detection cartridges that are designed